Japanese Encephalitis (JE) is a viral infection caused by the Japanese Encephalitis Virus (JEV). It is primarily transmitted through the bite of infected mosquitoes, particularly of the Culex species. JE can lead to inflammation of the brain (encephalitis), which can result in severe neurological complications and even death.
Japanese Encephalitis Vaccine:
1. Types of JE Vaccines:Inactivated Vaccines: These vaccines contain killed forms of the virus and are considered safe for most people, including those with weakened immune systems.
Live Attenuated Vaccines: These vaccines contain weakened forms of the virus and are not recommended for certain groups, such as pregnant women and immunocompromised individuals.
2. Available JE Vaccines: JENVAC A single-dose, inactivated JE vaccine developed in collaboration with the National Institute of Virology, India. It is derived from a Vero cell line and prepared from an Indian strain (Kolar-821564XY) of the JE virus. JENVAC is reported to be safe and highly effective, providing protection against all known strains of Japanese Encephalitis.
3. Vaccination Schedule: The vaccination schedule for JE vaccines may vary depending on the specific vaccine being used. However, for JENVAC, a single dose has been shown to elicit a strong immune response, with high rates of sero-protection and sero-conversion.
4. Who Should Get Vaccinated? Individuals traveling to or residing in areas where JE is endemic or epidemic are recommended to get vaccinated.
The vaccine is particularly important for travelers planning to spend an extended period in rural or agricultural areas, especially during the transmission season.
Vaccination may also be recommended for certain high-risk groups, such as laboratory workers or individuals involved in handling animals.
Vaccination may also be recommended for certain high-risk groups, such as laboratory workers or individuals involved in handling animals.
5. Vaccine Safety: JE vaccines, including JENVAC, are generally considered safe and well-tolerated.
Common side effects may include mild pain or redness at the injection site, headache, or fatigue.
Serious adverse reactions are rare.
6. Effectiveness: JE vaccines, when administered according to the recommended schedule, provide high levels of protection against Japanese Encephalitis.
As demonstrated by studies, a single dose of JENVAC has shown to be highly effective in inducing immune response and providing protection against the disease.
Conclusion:
Japanese Encephalitis vaccine, such as JENVAC, plays a crucial role in preventing the spread of this potentially devastating disease. With its high effectiveness and safety profile, it is an essential tool for travelers and individuals residing in areas where JE is endemic or epidemic. Vaccination not only protects individuals from the serious consequences of JE but also contributes to the overall public health efforts to control the spread of the virus.
Expertise Report
NCBI: Japanese Encephalitis
NCVBDC: Japanese Encephalitis
Bharat Biotech: Japanese Encephalitis
Healthychildren.org: Japanese Encephalitis
|| THANK YOU||
No comments:
Post a Comment